- Health A to Z
Healthline Premium Tools
Advertisement
Marketplace
|
... years, eye doctors have been using Avastin off-label as a treatment for retinal diseases, particularly age-related macular degeneration, the leading cause of blindness in the elderly. Avastin is similar in its mechanism of action to Lucentis, a drug ...
|
|
A new study reports that transplanted pigment-containing visual cells derived from human embryonic stem cells successfully preserved structure and function of the specialized light-sensitive lining of the eye in an animal model of retinal degeneration.
|
|
Main Category: Eye Health / Blindness Also Included In: Diabetes ; Heart Disease Article Date: 02 Oct 2009 - 1:00 PDT Highlights of October's Ophthalmology , the journal of the American Academy of Ophthalmology, include good news on preserving vision in people with type 1 diabetes , a warning from the Cardiovascular Health Study for macular ...
|
|
... is currently manufactured by Tolmar. QLT has been selling off assets since it announced a plan to focus on its macular degeneration treatment Visudyne. "Eligard has been a very strong revenue stream for us and we believe this deal reflects the ...
|
|
... and vision. It can lead to mouth cancer and gum disease, and is thought to be a contributing factor to age-related macular degeneration (AMD), a leading cause of preventable blindness. Other frontline NHS and social care staff will also be able to ...
|
|
... years, eye doctors have been using Avastin off-label as a treatment for retinal diseases, particularly age-related macular degeneration , the leading cause of blindness in the elderly. Avastin is similar in its mechanism of action to Lucentis, a ...
|
|
... to the success of marketed antibody products, including LUCENTIS(R) (ranibizumab injection) for wet age-related macular degeneration and CIMZIA(R) (certolizumab pegol) for rheumatoid arthritis and Crohn's disease. The company has a premier antibody ...
|
|
Highlights of October's Ophthalmology , the journal of the American Academy of Ophthalmology, include good news on preserving vision in people with type 1 diabetes, a warning from the Cardiovascular Health Study for macular degeneration patients, and a report on how vision impacts well-being across the lifespan.
|
|
... - meaning conditions where medication and lifestyles changes can have an impact. Conditions include age-related macular degeneration, colon cancer, coronary artery disease, inflammatory bowel disease, lupus, melanoma, obesity, prostate cancer, ...
|
|
... could not adequately express how much it meant to him that Pat was there to help him as the Parkinson's Disease and macular degeneration increasingly took their toll. The members of his family who could not be there to help recognize how important ...
|
|
... of vision loss in the industrial world: in people with diabetes, in babies born very early, and in age-related macular degeneration. The study has wide-ranging clinical implications, experts say, not only for finding new ways to curb vision loss but ...
|
|
... Phase 2 study, running concurrently with the pivotal Phase 3 FAME(TM) Study (Fluocinolone Acetonide in Diabetic Macular Edema), is designed primarily to assess systemic exposure of the corticosteroid, fluocinolone acetonide (FA), after ...
|
|
Indiana University School of Medicine research and a federal small business grant have set an Indianapolis startup company on a path to develop potential new treatments for age-related macular degeneration.
|
|
... OSUMC's patients and their primary care physicians with risk assessments for health conditions including age-related macular degeneration, colon cancer, coronary artery disease, hemochromatosis, inflammatory bowel disease, lupus, melanoma, obesity, ...
|
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2009 Healthline Networks, Inc. All rights reserved.